Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × Injections × Clear all

Phase

Status

Completed 5 Not yet recruiting 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 17 Breast Neoplasms 17 Advanced Solid Tumors 11 Advanced Solid Tumor 11 Myelodysplastic Syndromes 9 Carcinoma, Non-Small-Cell Lung 8 Stomach Neoplasms 5 Recurrence 5 Prostatic Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 4 Solid Tumor 4 Neoplasms 4 Myeloproliferative Disorders 4 Triple Negative Breast Neoplasms 3 Solid Tumors 3 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Advanced Solid Tumour 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Metastatic Castration-resistant Prostate Cancer (mCRPC) 2 Melanoma 2

Interventions

Doxorubicin 14 pembrolizumab 9 Gemcitabine 8 Surgical Procedures, Operative 7 Nivolumab 6 Blood Specimen Collection 6 Trabectedin 5 Surveys and Questionnaires 5 Ifosfamide 5 Drug Therapy 5 Cyclophosphamide 5 Radiotherapy 4 Radiation Dose Hypofractionation 4 liposomal doxorubicin 3 fludarabine 3 atezolizumab 3 anlotinib 3 Radiation 3 Observation 3 Ipilimumab 3 Docetaxel 3 Biopsy 3 trastuzumab deruxtecan 2 selinexor 2 repotrectinib 2 pazopanib 2 fluzoparib 2 fludarabine phosphate 2 eribulin 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04719156 2026-02-20

ICGTM

University of Pittsburgh

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡